A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

NCT03496623 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

188

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Pulmonary Hypertension
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Inhaled treprostinil solution
DRUG: Placebo solution

Sponsor

United Therapeutics